Bristol-Myers Squibb Co (BMY)
53.66
+0.41
(+0.77%)
USD |
NYSE |
Mar 28, 10:10
Bristol-Myers Squibb Gross Profit (TTM): 34.31B for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 34.31B |
September 30, 2023 | 34.39B |
June 30, 2023 | 34.80B |
March 31, 2023 | 35.62B |
December 31, 2022 | 36.02B |
September 30, 2022 | 36.84B |
June 30, 2022 | 37.31B |
March 31, 2022 | 37.39B |
December 31, 2021 | 36.44B |
September 30, 2021 | 34.97B |
June 30, 2021 | 33.68B |
March 31, 2021 | 31.86B |
December 31, 2020 | 30.74B |
September 30, 2020 | 28.04B |
June 30, 2020 | 24.22B |
March 31, 2020 | 21.09B |
December 31, 2019 | 18.07B |
September 30, 2019 | 16.98B |
June 30, 2019 | 16.80B |
March 31, 2019 | 16.58B |
December 31, 2018 | 16.09B |
September 30, 2018 | 15.58B |
June 30, 2018 | 15.21B |
March 31, 2018 | 14.71B |
December 31, 2017 | 14.76B |
Date | Value |
---|---|
September 30, 2017 | 14.75B |
June 30, 2017 | 14.69B |
March 31, 2017 | 14.78B |
December 31, 2016 | 14.46B |
September 30, 2016 | 13.96B |
June 30, 2016 | 13.31B |
March 31, 2016 | 12.80B |
December 31, 2015 | 12.65B |
September 30, 2015 | 12.61B |
June 30, 2015 | 12.55B |
March 31, 2015 | 12.30B |
December 31, 2014 | 11.95B |
September 30, 2014 | 11.82B |
June 30, 2014 | 11.80B |
March 31, 2014 | 11.84B |
December 31, 2013 | 11.77B |
September 30, 2013 | 11.71B |
June 30, 2013 | 11.57B |
March 31, 2013 | 11.83B |
December 31, 2012 | 13.01B |
September 30, 2012 | 13.98B |
June 30, 2012 | 15.17B |
March 31, 2012 | 15.93B |
December 31, 2011 | 15.65B |
September 30, 2011 | 15.26B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
16.58B
Minimum
Mar 2019
37.39B
Maximum
Mar 2022
29.81B
Average
34.00B
Median
Gross Profit (TTM) Benchmarks
Amgen Inc | 19.74B |
Gilead Sciences Inc | 20.62B |
Johnson & Johnson | 63.01B |
Karuna Therapeutics Inc (DELISTED) | -- |
2seventy bio Inc | 83.47M |